Equity Analysis

Quarterly Results

    Trident Lifeline Ltd
    Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
    BSE Code
    ISIN Demat
    Book Value()
    543616
    INE0MKA01014
    51.3768784
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    N.A
    30.59
    316.23
    EPS(TTM)
    Face Value()
    Div & Yield %:
    8.99
    10
    0
     
Quarters
(RupeeIcon Cr)
ParticularsSep 2024Jun 2024Mar 2024
Gross Sales15.6614.7418.99
Other Operating Income0.000.000.00
Other Income 0.520.471.26
Total Income16.1815.2120.25
Total Expenditure 11.2410.6616.03
PBIDT4.944.554.22
Interest 0.270.200.14
PBDT4.674.354.08
Depreciation0.160.330.19
Tax1.121.011.07
Fringe Benefit Tax0.000.000.00
Deferred Tax0.000.000.37
Reported Profit After Tax3.393.012.45
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item3.393.012.45
EPS (Unit Curr.)2.952.622.13
EPS (Adj) (Unit Curr.)2.952.622.13
Calculated EPS (Unit Curr.)2.952.622.13
Calculated EPS (Adj) (Unit Curr.)2.952.622.13
Calculated EPS (Ann.) (Unit Curr.)11.8010.488.51
Calculated EPS (Adj) (Ann.) (Unit Curr.)11.8010.488.51
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity11.5011.5011.50
Reserve & Surplus0.000.000.00
Face Value10.0010.0010.00
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
PBIDTM(%)31.5530.8722.22
PBDTM(%)29.8229.5121.48
PATM(%)21.6520.4212.90
Dividend Per Share(Rs)0.000.000.00
Diluted EPS2.952.622.13